https://www.selleckchem.com/pr....oducts/Aloxistatin.h
096, 95%CI 1.840-5.211, p0.001), and presence of lesions in spinal cord (HR 0.573, 95%CI 0.297-0.989, p=0.042) increased the risk of conversion from RRMS to SPMS. No significant difference between escalation and EIT groups in the risk of transition to progressive phase (weighted HR=1.438; 95% CI 0.963, 2.147; p=0.076) was found. Our data support previous observations that smoking is a modifiable risk factor for secondary progressive MS and confirms that spinal cord involvement, age, and more severe disease at onset are prognosti
Beğen
Yorum Yap
Paylaş
